Literature DB >> 9770561

Parkinson's disease. Second of two parts.

A E Lang1, A M Lozano.   

Abstract

At no time in the past have the basic and clinical sciences applied to Parkinson's disease been so active. Experimental therapies under study at present promise to improve on the limitations of existing treatments. Future progress in understanding the causation and pathogenesis of the disorder will permit the development of new treatments that will slow, halt, or even reverse the currently inexorable progressive course of Parkinson's disease.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9770561     DOI： 10.1056/NEJM199810153391607

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


  280 in total

Review 1.  Multiple system atrophy: pathophysiology and management.

Authors:  G K Wenning; S Braune
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 2.  Pharmacological treatment of Parkinson's disease.

Authors:  A Münchau; K P Bhatia
Journal:  Postgrad Med J       Date:  2000-10       Impact factor: 2.401

Review 3.  Rare genetic mutations shed light on the pathogenesis of Parkinson disease.

Authors:  Ted M Dawson; Valina L Dawson
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

Review 4.  Current concepts in the diagnosis and management of Parkinson's disease.

Authors:  Mark Guttman; Stephen J Kish; Yoshiaki Furukawa
Journal:  CMAJ       Date:  2003-02-04       Impact factor: 8.262

5.  Investigating neural correlates of behavior in freely behaving rodents using inertial sensors.

Authors:  Subramaniam Venkatraman; Xin Jin; Rui M Costa; Jose M Carmena
Journal:  J Neurophysiol       Date:  2010-04-28       Impact factor: 2.714

Review 6.  High frequency deep brain stimulation of the subthalamic nucleus versus continuous subcutaneous apomorphine infusion therapy: a review.

Authors:  R Carron; V Fraix; C Maineri; E Seigneuret; B Piallat; P Krack; P Pollak; A L Benabid; Stéphan Chabardès
Journal:  J Neural Transm (Vienna)       Date:  2010-12-29       Impact factor: 3.575

7.  Stem cell grafting improves both motor and cognitive impairments in a genetic model of Parkinson's disease, the aphakia (ak) mouse.

Authors:  Jisook Moon; Hyun-Seob Lee; Jun Mo Kang; Junpil Park; Amanda Leung; Sunghoi Hong; Sangmi Chung; Kwang-Soo Kim
Journal:  Cell Transplant       Date:  2012-10-02       Impact factor: 4.064

Review 8.  Current perspective of mitochondrial biology in Parkinson's disease.

Authors:  Navneet Ammal Kaidery; Bobby Thomas
Journal:  Neurochem Int       Date:  2018-03-14       Impact factor: 3.921

9.  The relationship between Parkinson's disease symptoms and caregiver quality of life.

Authors:  Richard S Henry; Sarah K Lageman; Paul B Perrin
Journal:  Rehabil Psychol       Date:  2020-02-17

10.  Are there adaptive changes in the human brain of patients with Parkinson's disease treated with long-term deep brain stimulation of the subthalamic nucleus? A 4-year follow-up study with regional cerebral blood flow SPECT.

Authors:  Stelvio Sestini; Alberto Pupi; Franco Ammannati; Ramat Silvia; Sandro Sorbi; Antonio Castagnoli
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-05-04       Impact factor: 9.236
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.